Application no. and date | 16823350.0 (espacenet) (Federated) (European Patent Register), 20161219 | Patent/reg. no. and date | DK/EP 3394259, 20240228 | Publication date | 20181031 | Priority no. and date | US 201562270165 P, 20151221 | EP pub. no. and date |
EP 3394259 20181031 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35 4056 Basel, CH | Applicant ref. no. | 169733/BT/GP | Inventor | POLYDORO OFENGEIM, Manuela, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Ave.
Cambridge, MA 02139, US, WEILER, Jan, Novartis Institutes for BioMedical Research Inc. 250 Massachusetts Ave.
Cambridge, MA 02139, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/7115 (2006.01) , A61K 31/712 (2006.01) , A61K 31/7125 (2006.01) , C12N 15/113 (2010.01) , A61P 25/28 (2006.01) | Title | SAMMENSÆTNINGER OG FREMGANGSMÅDER TIL REDUCERING AF TAU-EKSPRESSION | Int. application no. | IB2016057794 | Int. publication no. | WO2017109679 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|